Drug Res (Stuttg) 2013; 63(10): 510-514
DOI: 10.1055/s-0033-1349865
Original Article
© Georg Thieme Verlag KG Stuttgart · New York

Development and Validation of RP-HPLC Method for Simultaneous Estimation of Glimepiride and Sildenafil Citrate in Rat Plasma-Application to Pharmacokinetic Studies

A. S. Tripathi
1   Department of Pharmacology, P. Wadhwani College of Pharmacy, Maharashtra, India
,
A. P. Dewani
2   Department of Quality Assurance, P. Wadhwani College of Pharmacy, Maharashtra, India
,
P. G. Shelke
3   Department of Pharmaceutical Chemistry, P. Wadhwani College of Pharmacy, Maharashtra, India
,
R. L. Bakal
2   Department of Quality Assurance, P. Wadhwani College of Pharmacy, Maharashtra, India
,
A. V. Chandewar
3   Department of Pharmaceutical Chemistry, P. Wadhwani College of Pharmacy, Maharashtra, India
,
P. M. Mazumder
4   Department of Pharmaceutical Sciences, Birla Institute of Technology, Jharkhand, India
› Author Affiliations
Further Information

Publication History

received 25 January 2013

accepted 03 May 2013

Publication Date:
24 July 2013 (online)

Abstract

A simple and sensitive method was developed for simultaneous estimation of Glimepiride (GLIM) and Sildenafil citrate (SIL) in rat Plasma by reverse phase high performance liquid chromatography (RP-HPLC). The drug samples were extracted by liquid-liquid extraction with 300 µl of acetonitrile and 5 ml of diethyl ether. Chromatographic separation was achieved on C18 column using methanol: water (85:15 v/v) as mobile phase at a flow rate of 1 ml/min and UV detection at 230 nm. The retention time of GLIM and SIL was found to be 2.5 and 4.0 min respectively with total run time of 7 min. The developed method was validated for accuracy, precision, linearity and recovery. The method was linear and found to be acceptable over the range of 100–12 000 ng/ml. The method was successfully applied for the analysis of rat plasma sample for application to pharmacokinetic.

 
  • References

  • 1 Tripathi KD. Essential of medical pharmacology, jaypee brothers medical publisher(p) ltd. 6th edition 2009: 266
  • 2 Vardi M, Nini A. Phosphodiesterase inhibitors for erectile dysfunction in patients with diabetes mellitus. Cochrane Database Syst Rev 2007; 1 CD002187 DOI: 10.1002/14651858.CD002187. pub3. PMID 17253475.
  • 3 Jeong KH, Lee TW, Ihm CG et al. Effects of sildenafil on oxidative and inflammatory injuries of the kidney in streptozotocin-induced diabetic rats. Am J Nephrol 2009; 29: 274-282
  • 4 Roche ME, Oda RP, Lawson GM et al. Capillary Electrophoretic Detection of Metabolites in the Urine of Patients Receiving Hypoglycemic Drug Therapy. Electrophoresis 1997; 18: 1865-1874 DOI: 10.1002/elps.1150181024.
  • 5 Jingar JN, Rajput SJ, Dasandi B et al. Development and Validation of LC-UV for Simultaneous Estimation of Rosiglitazone and Glimepiride in Human Plasma. Chromatographia 2008; 67: 951-955 DOI: 10.1365/s10337-008-0633-3.
  • 6 Song YK, Maeng JE, Hwang HR et al. Determination of Glime-piride in Human Plasma Using Semi-Microbore High-Performance Liquid Chromatography with Column switching. Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences 2004; 810: 143-149
  • 7 Khan IU, Aslam F, Ashfaq M et al. Determination of Glimepiride in Pharmaceutical Formulations Using High-Performance Liquid Chromatog-raphy and First-Derivative Spectrophotometric Methods. Journal of Analytical Chemistry 2009; 64: 171-175 DOI: 10.1134/S1061934809020130.
  • 8 Salem II, Idrees J, Al Tamimi JI. Determination of Glimepiride in Human Plasma by Liquid Chromatography Electrospray Ionization Tandem Mass Spectro- metry. Journal of Chromatography B: Analytical Tech-nologies in the Biomedical and Life Sciences. 2004 799. 103-109 DOI: 10.1016/j.jchromb.2003.10.024
  • 9 Kim H, Chang KY, Lee HJ et al. Determination of Glimepiride in Human Plasma by Liquid Chromatography — Electrospray Ionization Tandem Mass Spectrometry. Bulletin of the Korean Chemical Society 2004; 25: 109-114 DOI: 10.5012/bkcs.2004.25.1.109.
  • 10 Kim H, Chang KY, Park CH et al. Determination of Glimepiride in Human Plasma by LC-MS-MS and Comparison of Sample Preparation Methods for Glimepiride. Chromatographia 2004; 60: 93-98 DOI: 10.1365/s10337-004-0351-4.
  • 11 Yuzuak N, Ozden T, Eren S et al. Determination of Glimepiride in Human Plasma by LC-MS-MS. Chromatographia 2007; 66: 165-168 DOI: 10.1365/s10337-007-0368-6.
  • 12 Pawar SP, Meshram GA, Phadke MU. Simultaneous LC Estimation of Glimepiride and Metformin in Glimepiride Immediate Release and Metformin Sustained Release Tablets. Chromatographia 2008; 68: 1063-1066 DOI: 10.1365/s10337-008-0802-4.
  • 13 Lehr KH, Damm P. Simultaneous Determination of the Sulphonylurea Glimepiride and Its Metabolites in Human Serum and Urine by High-Performance Liquid Chromatography after PreColumn Derivatization. Journal of Chromatography-Biomedical Applications 1990; 526: 497-505 DOI: 10.1016/S0378-4347(00)82531-1.
  • 14 The United States Pharmacopeia (USP) and the National Formulary (NF) . The Official Compendia of Standards 2006; 29: 1001
  • 15 Pathare DB, Jadhav AS, Shingare MS. RP-LC Determination of the Cis-Isomer of Glimepiride in a Bulk Drug Substance. Chromatographia 2007; 66: 639-641 DOI: 10.1365/s10337-007-0356-x.
  • 16 Saisho K, Scott KS, Morimoto S et al. Extraction and determination of sildenafil (Viagra) and its N-desmethyl metabolite in rat and human hair by. GC-MS. Biol Pharm Bull 2001; 24: 1384-1388
  • 17 Nevado JJB, Flores JR, Penalvo GC et al. Determination of sildenafil citrate and its main metabolite by sample stacking with polarity switching using micellar electrokinetic chromatography. J Chromatogr A 2002; 953: 279-286
  • 18 Weinmann W, Bohnert M, Wiedemann A et al. Post-mortem detection and identification of sildenafil (Viagra) and its metabolites by LC/MS and LC/MS/MS. Int J Legal Med 2001; 114: 252-258
  • 19 Dumestre-Toulet V, Cirimele V, Gromb S et al. Last performance with VIAGRA®: post-mortem identification of sildenafil and its metabolites in biological specimens including hair sample. Forensic Sci Int 2002; 126: 71-76
  • 20 Eerkes A, Addison T, Naidong W. Simultaneous assay of sildenafil and desmethylsildenafil in human plasma using liquid chromatography – tandem mass spectrometry on silica column with aqueous organic mobile phase. J Chromatogr B 2002; 768: 277-284
  • 21 Kim J, Ji H, Kim S et al. Simultaneous determination of sildenafil and its active metabolite UK-103,320 in human plasma using liquid chromatography – tandem mass spectrometry. J Pharm Biomed Anal 2003; 32: 317-322
  • 22 Wang L, Wang J, Cui Y et al. Liquid chromatographic – tandem mass spectrometric method for the quantitation of sildenafil in human plasma. J Chromatogr B 2005; 828: 118-121
  • 23 Hyland R, Roe EGH, Jones BC et al. Effect of P-glycoprotein modulation on the clinical pharmacokinetics and adverse effects of morphine Br. J. Clin Pharmacol 2000; 51: 239-248
  • 24 Cooper JDH, Muirhead DC, Taylor JE et al. Development of an assay for the simultaneous determination of sildenfail (viagra) and its metabolite (UK-103,320) using automated sequential trace enrichment of dialysates and high-performance liquid chromatography. J Chromatogr B 1997; 701: 87-95
  • 25 Jeong CK, Lee HY, Jang MS et al. Narrowbore high-performance liquid chromatography for the simultaneous determination of sildenafil and its metabolite UK-103,320 in human plasma using column switching. J Chromatogr B 2001; 752: 141-147
  • 26 Liaw J, Chang TW. Determination of transdermal sildenafil in nude mouse skin by reversed-phase high-performance liquid chromatography. J Chromatogr B 2001; 765: 161-166
  • 27 Guermouchea MH, Bensalah K. Solid phase extraction and liquid chromatographic determination of sildenafil and N-demethylsidenafil in rat serum with basic mobile phase. J Pharm Biomed Anal 2006; 40: 952-957